MALAT1 and neoplasm: MALAT-1 is upregulated in some types of uterine cancers, and studies have suggested that it may act as a biomarker for distinguishing between proliferative and secretory phases of endometrial cancer as expression patterns for MALAT-1 was similar in both ESS tumor cells and normal stromal cells during proliferation phase but in the secretory phase it was substantially lower.